News

DPP-4 Inhibitors May Be Cardioprotective

View on the News

Risk Reduction - Hope, But Don't Bet Yet

This meta-analysis offers some reassurance to those of us who continue to be concerned about the cardiovascular safety of any drug. When we get all the data for the DPP-4–inhibitor trials and the GLP-1 analogues, and examine cardiovascular events for these outcomes, we’ll know much more. But we are getting preclinical data that look positive, so we’re moving in the right direction.

The preclinical data suggest that the DPP-4 inhibitors may act directly on the heart, induce vasodilation, and improve endothelial function. But right now, we cannot separate those benefits from the improved metabolic profile that the drugs induce, so I don’t want to raise hopes too much.

Carolyn Deacon, M.D., is a medical physiologist at Panum Institute in Copenhagen. She disclosed a number of relationships with pharmaceutical companies involved in diabetes research. Her spouse is an employee of Merck.


 

FROM THE ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES

Dr. Mannucci disclosed relationships with Astra Zeneca, Boehringer Ingelheim, Eli Lilly Merck, Bristol-Myers Squibb, Novartis, and Takeda. Dr. Deacon disclosed a number of relationships with pharmaceutical companies involved in diabetes research.

Pages

Recommended Reading

Diabetes Patients Require More Realistic Exercise Goals
MDedge Family Medicine
Exercise and Diabetes Pose a Catch-22
MDedge Family Medicine
Little Difference Between Weekly Exenatide and Daily Liraglutide
MDedge Family Medicine
Insulin-Dependent Diabetes Portends Poor Angiography Outcomes
MDedge Family Medicine
Investigational Glucagon Antagonists Show Promise for Diabetes
MDedge Family Medicine
Continuous Glucose Monitor Accurate Post-Cardiac Surgery
MDedge Family Medicine
Intestinal Device Mimics Bariatric Surgery's Antidiabetic Effects
MDedge Family Medicine
Bloodstream Infections Spiked With Loss of Short-term Glucose Control
MDedge Family Medicine
UN Adopts Noncommunicable Disease Declaration
MDedge Family Medicine
Fatty Liver Ups Risk of Cardiovascular Disease
MDedge Family Medicine